[ Price : $8.95]
FDA approves Amgens Bkemv as an interchangeable biosimilar for Alexions Soliris, indicated to treat two rare diseases.[ Price : $8.95]
Johnson & Johnson reports positive topline results from its pivotal Phase 3 MDD3001 clinical trial evaluating the efficacy and saf...[ Price : $8.95]
The American Clinical Laboratory Association and HealthTrackRX sue FDA to block the agencys final rule asserting authority over la...[ Price : $8.95]
FDA grants Eli Lilly accelerated approval for Retevmo (selpercatinib) for pediatric patients two years of age and older with advan...[ Price : $8.95]
Federal Register notice: FDA seeks comments on an OMB information collection extension entitled De Novo Classification Process (Ev...[ Price : $8.95]
Federal Register notice: FDA announces the issuance of an emergency use authorization for Invivyds Pemgarda (pemivibart) for use a...[ Price : $8.95]
FDA warns Chinas Ostar Beauty Sci-Tech about illegally marketing unapproved medical devices.[ Price : $8.95]
FDA warns Charlottesville, VA-based ION Intelligence of Nature about multiple violations in its production of drugs and dietary su...